What evidence‑based, low‑risk treatments can be used to promote hair regrowth in adults?

Evidence-Based Hair Regrowth Treatments

For adults with hair loss, topical minoxidil (2-5%) is the first-line treatment with the strongest evidence for efficacy and safety, while low-dose oral minoxidil (0.25-5 mg daily) represents an effective alternative when topical therapy fails or causes skin irritation. 1, 2

Primary Treatment Approach

Topical Minoxidil

• Start with minoxidil 2% or 5% applied twice daily as your initial therapy 3
• Moderate-quality evidence shows participants using minoxidil are nearly twice as likely to experience moderate-to-marked hair regrowth compared to placebo (RR 1.93) 3
• Expect an increase of approximately 13 hairs per cm² compared to baseline 3
• No clinically meaningful difference exists between 2% and 5% concentrations in terms of efficacy or adverse events, though both work 3
• Common side effects include transient shedding during the first 3 months, unwanted facial hair growth (hypertrichosis), and contact dermatitis from inactive ingredients like propylene glycol 1

Low-Dose Oral Minoxidil (LDOM)

Consider oral minoxidil when:

• Topical minoxidil causes skin irritation or allergy 1
• Patient adherence to topical application is poor
• Scalp application is impractical

Dosing strategy:

• Start at 0.25-1.25 mg daily for women, 2.5 mg daily for men 2
• Titrate gradually based on response and tolerability
• Maximum doses typically 2.5 mg for women, 5 mg for men 1

Mandatory precautions before prescribing LDOM:

• Obtain cardiology or primary care consultation if any of these exist: 1
  • History of tachycardia or arrhythmia
  • Blood pressure <90/60 mm Hg
  • Kidney impairment or dialysis
  • Any identified contraindications

Absolute contraindications:

• Hypersensitivity to minoxidil 1
• Severe cardiovascular disease

Expected side effects:

• Hypertrichosis (unwanted hair growth) occurs most commonly on sideburns and temples within first 3 months, resolves 1-6 months after stopping 2
• Women with existing hirsutism should continue usual hair removal methods or antiandrogens 2

Combination Therapies for Enhanced Results

For Men

Finasteride 1 mg daily combined with minoxidil shows the highest efficacy (SUCRA 80.18%) among male-specific treatments 4

• However, finasteride alone shows no benefit over placebo for female pattern hair loss 3
• Be aware of sexual dysfunction and neuropsychiatric side effects with finasteride 5

For Women

Microneedling combined with minoxidil demonstrates superior efficacy (SUCRA 87.18%) among female combination therapies 4

Advanced Combinations

Platelet-rich plasma (PRP) plus basic fibroblast growth factor with minoxidil showed the highest overall efficacy across all treatments (SUCRA 93.06%), producing an additional 35 hairs/cm² compared to minoxidil alone 4

Adjunctive Low-Risk Options

Low-Level Laser Therapy (LLLT)

• Laser comb devices show inconsistent participant-reported outcomes but demonstrate measurable increases in total hair count (17-18 additional hairs/cm²) 3
• Works by stimulating follicle repair, prolonging growth phase, and promoting anagen extension 6
• Enhanced outcomes when combined with minoxidil or finasteride 6
• Well-tolerated with minimal adverse effects 6

Platelet-Rich Plasma (PRP)

• Moderate-to-strong evidence in androgenetic alopecia with increases of 10-30 hairs/cm² in randomized trials 7
• Most evidence-supported adjuvant therapy in hair transplantation contexts 7
• Requires standardized protocols for optimal results 7

Critical Pitfalls to Avoid

Do not prescribe oral minoxidil without:

• Screening for cardiovascular contraindications 1
• Discussing hypertrichosis risk, especially with female patients 2
• Establishing specialty consultation pathways for high-risk patients 1

Warn patients about:

• Initial shedding phase (first 3 months) with both topical and oral minoxidil—this is expected and indicates treatment is working 1
• Lifelong treatment requirement—hair loss resumes after discontinuation 2
• Timeline expectations—visible results typically require 6-12 months of consistent use

Treatment Resistance Patterns

Be aware that some treatments show resistance effects after 12-16 weeks: 8

• Minoxidil 2% and 5% may lose some regrowth after initial gains
• Finasteride and dutasteride responses plateau
• LLLT, Nutrafol, and Viviscal show attenuated regrowth rates after 12 weeks
• Exception: Natural formulations like ALRV5XR demonstrate linear/accelerated growth without resistance patterns 8

Pediatric Considerations

For patients under 18 years:

• Topical minoxidil 2% or smaller doses of 5% formulation can be used despite lack of FDA approval 2
• LDOM maximum 2.5 mg/day for ages 10-18, ≤0.5 mg/day for infants and young children 2
• Greater systemic absorption risk requires careful monitoring 2